Events

2012 Events Pending

November 30, 2011
Stem Cell Meeting on the Mesa
Conference - La Jolla, CA, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

November 3, 2011
Boston Angiogenesis Meeting (BAM)
Conference - Cambridge, MA, presentation by Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, R&D, Pervasis Therapeutics

September 19-21, 2011
Cell Therapy Commercialization Summit
Conference - Boston, MA, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

September 7-9, 2011
BioPharm America 2011
Conference - Boston, MA

September 12-15, 2011
Stem Cells USA & Regenerative Medicine Congress
Conference - Boston, MA, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

June 27-30, 2011
Bio Business Forum
Conference - Washington, D.C., presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

June 24, 2011
Redefining the Superhero: Emerging technology that goes beyond bionics to make life super
MHT's Emerging Technologies Forum - Cambridge, MA, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

June 9, 2011
TERMIS EU 2011 Annual Meeting
Conference - Granada, Spain, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

May 26-27, 2011
7th Stem Cell Research and Therapeutics
Conference - Boston, MA, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

May 9-11, 2011
World Stem Cells & Regenerative Medicine Congress
Conference - London, UK, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

April 2-6, 2011
American Association for Cancer Research (AACR) Annual Meeting
Conference - Orlando, FL, "A first in class novel cell therapy (PVS-30200) for the treatment and prevention of metastic cancer by regulating the tumor microenvironment"; Late-Breaking Research Session by Joseph W. Franses, Ph.D., MIT, April 5, 4:15 pm

March 10-11, 2011
Cell Therapy Summit (CTS) Europe
Conference - Maastricht, the Netherlands, presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics

March 1, 2011
6th Annual New York Stem Cell Summit 2011
Conference - New York, NY, "Adult Stem Cells" presentation by Frederic Chereau; President and CEO, Pervasis Therapeutics at 2:23 pm

February 11-13, 2011
American Society of Diagnostic & Interventional Nephrology (ASDIN) 7th Annual Scientific Meeting
Conference - Las Vegas, NV, "Our Current Understanding of Vascular Access Biology and Future Directions" presentation by Prabir Roy-Chaudhury, M.D., Ph.D. on Saturday, February 12, 8:00 am

January 20-21, 2011
6th Annual International Conference on Cell Therapy for Cardiovascular Disease
Conference - New York, NY, "Cell-Based Therapy for the Treatment of Restenosis in PAD: The TRIUMPH Trial" presentation by Jean-Marc Alsac, M.D. on Thursday, January 20, 2:35 pm

November 30, 2010
Careers in Science and Research Forum
Open Forum - University of Massachusetts, Boston, panel with Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics

November 18-19, 2010
8th Annual Commercial Translation of Regenerative Medicine
Conference - London, UK, "Expectations of Big Pharmaceuticals" panel with Frederic Chereau; President and CEO, Pervasis Therapeutics

November 17-21, 2010
Veith Symposium
Conference - New York, NY

November 16-21, 2010
ASN Renal Week
Conference - Denver, CO, Bioengineering and Informatics poster presentation from Prabir Roy-Chaudhury, M.D., Ph.D. on Friday, November 19, 10:00 am - 2:30 pm

November 16-17, 2010
MIT Research and Development Conference
Conference - Cambridge, MA, Exhibit presentation with Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics on Tuesday, November 16, 12:00 pm - 2:00 pm

October 1-2, 2010
Cincinnati Hemodialysis Vascular Access Symposium 2010
Conference - Cincinnati, OH

September 21-25, 2010
TCT 2010
Conference - Washington, DC

September 15-17, 2010
BioPharm America 2010
Conference - Boston, MA, "Regenerative Medicine: Bridging the Gap Between Science and Commercial Success"; presentation with Frederic Chereau; President and Chief Executive Officer, Pervasis Therapeutics

September 13-15, 2010
Stem Cells USA & Regenerative Medicine Congress 2010
Conference - Philadelphia, PA, Autologous vs. Allogeneic; panel presentation with Josh Hamermesh, SVP, Strategy and Corporate Development, Pervasis Therapeutics

June 13-17, 2010
Termis - Tissue Engineering & Regenerative Medicine International Society
Conference - Galway, Ireland, Lessons Learned from Start-Ups/SME in Regenerative Medicine; "Cardiovascular and Neuro - cardiac tissue, vessels, and angiogenesis; and peripheral nerve regeneration"; panel presentation with Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics

May 25-27, 2010
EuroPCR 2010
Conference - Paris, France, "Innovation Incubator" with Frederic Chereau; President and Chief Executive Officer, Pervasis Therapeutics

May 12-14, 2010
Vascular Access for Hemodialysis XII Symposium
Conference - Las Vegas, NV, "Vascugel Treatment after the Creation of Arteriovenous Access, an Extension Study" abstract presentation by Jeffrey Lawson, MD; Duke University Medical Center

May 11-13, 2010
World Stem Cells & Regenerative Medicine Congress 2010
Conference - London, UK, "A new approach to vascular healing using allogeneic stem cell technology" presented by Frederic Chereau; President and Chief Executive Officer, Pervasis Therapeutics

April 21-22, 2010
BIOMEDevice Forum
Conference - Boston, MA, "Disruptive Innovation: how convergent technology is redefining the life sector through improved medical outcomes and decreased healthcare costs" keynote panel presentation with Josh Hamermesh, SVP, Strategy and Corporate Development, Pervasis Therapeutics

April 13, 2010
IdeaStream 2010
Conference - Boston, MA, "Deshpande Center Grant Recipients & Spinouts" plenary session with Frederic Chereau; President and Chief Executive Officer, Pervasis Therapeutics

February 26, 2010
MHT 8th annual BioForum
Conference - Boston, MA, "High risks, high rewards: Avoiding the pitfalls of partnerships" panel presentation with Josh Hamermesh, SVP, Strategy and Corporate Development, Pervasis Therapeutics

January 26, 2010
Phacilitate 2010
Conference - Washington, DC, "Qualification of raw materials, impact of legacy materials" presented by Jack Harvey, Director of Manufacturing, Pervasis Therapeutics

November 17, 2009
Stem Cell USA & Regenerative Medical Congress - Washington D.C.
Technology & Science Updates by Therapeutic Application "Inflammatory" panel presentation with Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics

October 27, 2009
Boston Biotech Research & Development Conference - Harvard Medical School, Cambridge, MA
"Cell Therapies, Redefined" presented by Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics

June 8, 2009
13th Annual Goldman Sachs Global Healthcare Conference - New York, NY
Private Company Forum 3:30 pm presentated by Frederic Chereau; President and Chief Executive Officer, Pervasis Therapeutics

May 19-22, 2009
EuroPCR - Barcelona, Spain
Out-of-the-box innovations
"Percutaneous delivery of perivascular tissue engineered allogeneic endothelial cells minimizes intimal area and enhances vascular repair after endovascular peripheral interventions" presented by Helen Marie Nugent, Ph.D.; Co-Founder and Vice President, Research and Development, Pervasis Therapeutics